The most pondered-upon subject in the COVID-19 vaccine debates is: Is the vaccine safe for pregnant women? It turns out that the mRNA vaccines are safe for pregnant women and their babies.
According to a study indicated in the American Journal of Obstetrics & Gynecology – Maternal-Fetal Medicine on Wednesday, pregnant women who receive mRNA vaccines could transmit high levels of antibodies to their babies. The study is one of the initial studies to estimate the umbilical cord blood’s antibody levels to determine whether resistance is from vaccines or contagion. It discovered that 36 newborns examined at birth all carried antibodies to shield against COVID-19 following the inoculation with Moderna or Pfizer Inc.-BioNTech SE of their mothers.
Study May Help Pregnant Women to Receive Vaccination
An obstetrician at New York University Langone Health System and co-author of the study, Ashley Roman, stated, “We didn’t anticipate that. We expected to see more variability.” The findings may prompt more individuals to choose to be administered vaccination amid their expecting stage. According to the Centers for Disease Control and Prevention (CDC) data from September 11, merely 30% of pregnant women between 18 and 49 are inoculated, notwithstanding a mounting proof of prenatal vaccine safety.
Highest Level of Antibodies
Also, the research group was able to distinguish the difference between antibodies manufactured to respond to the vaccine and those made in response to natural infections. This is a significant factor because it has been exhibited that natural antibody responses against the novel coronavirus are not adequately shielding for numerous individuals. In order to retrieve such results, the team tested blood from the umbilical cord. It had the most significant levels of antibodies discovered in babies whose mother was fully inoculated amid the second half of the prenatal stage.
The authors of the study are currently overseeing findings from a bigger group. They are concentrating on the duration of the inoculation phase among infants following delivery. According to a co-author of the study, the findings of theirs study were published prematurely because it was an unprecedented finding with indications “for care.” The study indicates that 31 samples of pregnant women displayed no trace of nucleocapsid protein. This translates that the infants were born with a greater range of immunity because of the inoculation of the mothers.